These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10754382)

  • 1. The FVII activating protease cleaves single-chain plasminogen activators.
    Römisch J; Vermöhlen S; Feussner A; Stöhr H
    Haemostasis; 1999; 29(5):292-9. PubMed ID: 10754382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular histones promote fibrinolysis by single-chain urokinase-type plasminogen activator in a factor seven activating protease-dependent way.
    Semeraro F; Ammollo CT; Semeraro N; Colucci M
    Thromb Res; 2020 Dec; 196():193-199. PubMed ID: 32891905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
    Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of single-chain urokinase-type plasminogen activator by platelet-associated plasminogen: a mechanism for stimulation of fibrinolysis by platelets.
    Baeten KM; Richard MC; Kanse SM; Mutch NJ; Degen JL; Booth NA
    J Thromb Haemost; 2010 Jun; 8(6):1313-22. PubMed ID: 20180903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect.
    Pannell R; Gurewich V
    Blood; 1986 May; 67(5):1215-23. PubMed ID: 3083889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme.
    Kannemeier C; Feussner A; Stöhr HA; Weisse J; Preissner KT; Römisch J
    Eur J Biochem; 2001 Jul; 268(13):3789-96. PubMed ID: 11432747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of fibrin binding on the biochemical properties of single-chain tissue-type plasminogen activator (t-PA) and single-chain chimeric plasminogen activator (t-PA/scu-PA).
    Fischer BE
    Blood Coagul Fibrinolysis; 1992 Feb; 3(1):39-46. PubMed ID: 1320415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
    Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
    Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of single-chain urokinase-type plasminogen activator (scu-PA) in aprotinin treated cardiac surgical patients undergoing cardiopulmonary bypass.
    Spannagl M; Dooijewaard G; Dietrich W; Kluft C
    Thromb Haemost; 1995 May; 73(5):825-8. PubMed ID: 7482410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A protease isolated from human plasma activating factor VII independent of tissue factor.
    Römisch J; Feussner A; Vermöhlen S; Stöhr HA
    Blood Coagul Fibrinolysis; 1999 Dec; 10(8):471-9. PubMed ID: 10636458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein.
    Binnema DJ; Dooijewaard G; Turion PN
    Thromb Haemost; 1991 Feb; 65(2):144-8. PubMed ID: 1905069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of a plasma factor which cleaves single-chain form of t-PA and u-PA.
    Okada K; Fukao H; Tanaka H; Ueshima S; Matsuo O
    Thromb Res Suppl; 1990; 10():27-43. PubMed ID: 2156352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of standard heparin and a low molecular weight heparin on thrombolytic and fibrinolytic activity of single-chain urokinase plasminogen activator in vitro.
    Lourenço DM; Dosne AM; Kher A; Samama M
    Thromb Haemost; 1989 Nov; 62(3):923-6. PubMed ID: 2556812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of a novel low molecular weight form of single-chain urokinase-type plasminogen activator.
    Stump DC; Lijnen HR; Collen D
    J Biol Chem; 1986 Dec; 261(36):17120-6. PubMed ID: 3097021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of coagulation factor VII by tissue-type plasminogen activator.
    Tsujioka H; Suehiro A; Kakishita E
    Am J Hematol; 1999 May; 61(1):34-9. PubMed ID: 10331509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor seven activating protease (FSAP): does it activate factor VII?
    Stavenuiter F; Dienava-Verdoold I; Boon-Spijker MG; Brinkman HJ; Meijer AB; Mertens K
    J Thromb Haemost; 2012 May; 10(5):859-66. PubMed ID: 22235940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature of synergy between tissue-type and single chain urokinase-type plasminogen activators.
    Fry ET; Mack DL; Sobel BE
    Thromb Haemost; 1989 Nov; 62(3):909-16. PubMed ID: 2512679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve growth factor-gamma activates soluble and receptor-bound single chain urokinase-type plasminogen activator.
    Wolf BB; Vasudevan J; Henkin J; Gonias SL
    J Biol Chem; 1993 Aug; 268(22):16327-31. PubMed ID: 8393859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase.
    Dewerchin M; Vandamme AM; Holvoet P; De Cock F; Lemmens G; Lijnen HR; Stassen JM; Collen D
    Thromb Haemost; 1992 Aug; 68(2):170-9. PubMed ID: 1412163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolytic efficacy of Amediplase, Tenecteplase and scu-PA in different external plasma clot lysis models: sensitivity to the inhibitory action of thrombin activatable fibrinolysis inhibitor (TAFI).
    Guimarães AH; Barrett-Bergshoeff MM; Criscuoli M; Evangelista S; Rijken DC
    Thromb Haemost; 2006 Sep; 96(3):325-30. PubMed ID: 16953274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.